Guardant Health, Inc. (GH)
$167.47+1.15%Close
SELLBULL · day 20
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $22.2B
- Beta
- 1.58
- P/E (TTM)
- -48.91
- Short % float
- 9.32%
- Days to cover
- 6.2
- SI change
- +8.1%
- 1W
- -5.81%
- 1M
- +5.31%
- vs SPY 1W
- -6.97%
- vs SPY 1M
- +2.31%
Industry peers
FMP comparable companies · ranked by market cap
- NTRABUYNatera, Inc.$56.0BBULLQ 30$390.79+2.54%
- GRALBUYGRAIL Inc.$5.7BRECOVERYQ 68$132.61+6.01%
- BLLNSELLBillionToOne, Inc.$4.4BCRISISQ -7$95.41+2.81%
- PSNLSELLPersonalis, Inc.$1.7BRECOVERYQ 6$16.06-0.37%
- CSTLSELLCastle Biosciences, Inc.$1.0BRECOVERYQ 12$33.71+2.11%
- FLGTBUYFulgent Genetics, Inc.$591MRECOVERYQ 13$20.82+4.42%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on GH?
- LOPJLB’s latest quantitative signal on Guardant Health, Inc. (GH) is SELL in a BULL regime. Signals are updated daily.
- What market regime is GH in?
- Guardant Health, Inc. (GH) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Guardant Health, Inc. (GH) do?
- Guardant Health, Inc., established in Redwood City, California, in 2011, is a precision oncology company that delivers a range of diagnostic blood tests, comprehensive data sets, and advanced analytical solutions both within the United States and internationally. For patients with advanced-stage cancer, the company's core offerings include several liquid biopsy-based tests such as Guardant360 (…